Pathophysiology of Hyperbilirubinemia

Slide 1 · Pathophysiology of Hyperbilirubinemia

Bilirubin metabolism, jaundice, and cholestatic injury

Production

Conjugation

Excretion

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Trace bilirubin from heme catabolism to fecal and urinary elimination.

Distinguish unconjugated from conjugated hyperbilirubinemia mechanistically.

Explain common acquired, neonatal, and inherited causes of jaundice.

Recognize the morphologic and clinical consequences of cholestasis.

Apply bilirubin fractionation to focused clinicopathologic problems.

Slide 3 · Bilirubin homeostasis is a flux balance

Serum concentration stays stable when formation and elimination remain matched.

Heme breakdown

Hepatic uptake

Conjugation

Biliary excretion

Disruption at any point shifts bilirubin into plasma; The affected step helps determine which bilirubin fraction predominates.

Slide 4 · Recognizing jaundice: Concentration and appearance

Normal adult serum total bilirubin: 0.3–1.2 mg/dL.

Visible jaundice typically appears above 2–2.5 mg/dL.

Icterus denotes yellow discoloration of the conjunctiva.

Yellow coloration reflects bilirubin accumulation in tissues.

Mechanistic interpretation

The absence of visible jaundice does not exclude biochemical hyperbilirubinemia.

Slide 5 · Why bile is essential beyond bilirubin disposal

Bile carries bilirubin and excess cholesterol into the intestine.

It also eliminates xenobiotics and trace elements.

Bile salts act as detergents that emulsify dietary lipids.

Adequate bile delivery is therefore necessary for fat absorption.

Mechanistic interpretation

Impaired bile secretion couples jaundice to digestive and nutritional consequences.

Slide 6 · Major constituents of bile

Component

Primary role

Clinical implication

Bilirubin glucuronides

Heme pigment elimination

Retention produces jaundice

Bile salts

Lipid emulsification

Retention contributes to hepatocyte injury

Cholesterol

Excretion of excess sterol

Retention may cause xanthomas

Phosphatidylcholine

Micellar organization

Protects biliary surfaces

Bile is a coordinated secretion; Failure can retain several solutes simultaneously.

Slide 7 · Senescent erythrocytes supply most bilirubin

Aging erythrocytes are cleared by mononuclear phagocytes.

Spleen, liver, and marrow macrophages process their heme.

Approximately 85% of daily bilirubin to old erythrocytes.

Daily pigment production is described as 0.2–0.3 g.

Mechanistic interpretation

Accelerated red-cell turnover can exceed hepatic bilirubin processing capacity.

Slide 8 · Nonerythrocyte heme also generates bilirubin

The remainder arises from turnover of other heme-containing proteins.

Hepatic cytochrome P450 proteins are one source.

Thus bilirubin production continues independent of intact erythrocyte destruction.

The proportional contribution from each source varies with heme turnover.

Mechanistic interpretation

The essential precursor is heme, not the erythrocyte itself.

Slide 9 · Heme catabolism creates unconjugated bilirubin

Macrophage enzymes transform heme into a pigment requiring plasma transport.

Heme

Biliverdin

Unconjugated bilirubin

Heme oxygenase forms biliverdin; Biliverdin reductase forms bilirubin. Newly formed unconjugated bilirubin is poorly water soluble.

Slide 10 · Albumin makes circulating bilirubin transport possible

Unconjugated bilirubin is insoluble at physiologic pH.

It circulates predominantly bound to serum albumin.

The bilirubin–albumin complex delivers pigment to the liver.

Albumin-bound pigment is not freely filtered into urine.

Mechanistic interpretation

This binding explains why isolated unconjugated hyperbilirubinemia does not directly cause bilirubinuria.

Slide 11 · Hepatic processing requires ordered steps

The hepatocyte converts an insoluble pigment into an excretable conjugate.

Sinusoidal uptake

Intracellular handling

ER conjugation

Canalicular export

A defect at uptake or conjugation favors unconjugated accumulation; Disturbed excretion favors conjugated retention.

Slide 12 · Sinusoidal uptake is a potential bottleneck

The bilirubin–albumin complex arrives at the hepatocyte surface.

Bilirubin must enter across the sinusoidal plasma membrane.

Certain drugs can interfere with membrane carrier systems.

Reduced uptake is among the causes of unconjugated hyperbilirubinemia.

Mechanistic interpretation

A rise in serum bilirubin need not imply increased heme breakdown.

Slide 13 · UGT1A1 changes bilirubin solubility

Conjugation occurs in the hepatocyte endoplasmic reticulum.

Unconjugated bilirubin

UGT1A1 + glucuronic acid

Bilirubin glucuronides

Addition of one or two glucuronic acid residues produces mono- and diglucuronides that are water soluble.

Slide 14 · Conjugation changes physicochemical behavior

Unconjugated bilirubin

Conjugated bilirubin

Poorly water soluble

Strongly bound to albumin

Not excreted in urine

Water soluble

Less tightly albumin bound

May be excreted in urine

Solubility, not simply concentration, explains the distinctive urinary findings.

Slide 15 · Canalicular export completes hepatic disposal

Conjugation alone does not remove bilirubin from the body.

Bilirubin glucuronides

MRP2 transporter

Canalicular bile

Bile duct

MRP2 carries conjugated bilirubin across the canalicular membrane; Defects in export allow conjugated pigment retention.

Slide 16 · Canalicular transporters partition bile constituents

Transport system

Predominant transported material

MRP2

Conjugated bilirubin / organic anions

BSEP

Bile salts

MDR3

Phosphatidylcholine

Sterolin-1 / sterolin-2

Cholesterol

Different transporter defects disturb different aspects of bile formation.

Slide 17 · Bile acids sustain lipid digestion

Primary human bile acids include cholic and chenodeoxycholic acids.

Conjugation with glycine or taurine yields bile salts.

Bile acids combine with cholesterol and phospholipids in micelles.

Micelles aid sterol solubilization and reduce bile-acid injury to epithelium.

Mechanistic interpretation

Cholestasis impairs not just pigment elimination but intestinal lipid handling.

Slide 18 · Intestinal microbes alter bilirubin conjugates

Hepatic excretion is followed by bacterial processing in the gut.

Bilirubin glucuronides

Bacterial deconjugation

Urobilinogens

Fecal elimination

Intestinal bacterial β-glucuronidases deconjugate pigments; Residues and urobilinogens largely leave in feces.

Slide 19 · A fraction of urobilinogen recirculates

Elimination is accompanied by intestinal reabsorption.

Gut urobilinogen

Portal return

Hepatic re-excretion

Approximately 20% reabsorption in the ileum and colon, with most returned pigment re-excreted into bile.

Slide 20 · Why normal urine contains some pigment products

Some intestinal urobilinogen is reabsorbed into blood.

A small fraction of this reabsorbed product enters urine.

This urinary urobilinogen differs from conjugated bilirubinuria.

Unconjugated bilirubin remains poorly filterable because of albumin binding.

Mechanistic interpretation

Urinary bilirubin and urinary urobilinogen represent different points in pigment metabolism.

Slide 21 · Integrated pigment pathway: Source to excretion

The organ systems are sequentially linked.

Macrophage / heme

Blood / albumin

Hepatocyte / UGT1A1

Bile / MRP2

Intestine / flora

Normal homeostasis depends on all steps; An upstream or downstream failure produces a different pattern of hyperbilirubinemia.

Slide 22 · Four mechanisms raise serum bilirubin

Classification by failed step provides a mechanistic differential.

Excess production

Reduced uptake

Failed conjugation

Impaired excretion

The first three most often raise the unconjugated fraction; Excretion failure and cholestasis often raise conjugated bilirubin.

Slide 23 · Fractionation divides jaundice into useful pathways

Predominantly unconjugated

Predominantly conjugated

Prehepatic overproduction

Sinusoidal uptake defects

Impaired glucuronidation

Hepatocellular disease

Canalicular export disorders

Bile duct injury or obstruction

The fraction predominance narrows the differential; Mixed patterns can occur with liver disease.

Slide 24 · Clinical meaning of direct and indirect fractions

Measured fraction

Concept

Practical clue

Indirect (unconjugated)

Predominantly unglucuronidated bilirubin

Usually no bilirubinuria

Direct (conjugated)

Predominantly glucuronidated bilirubin

May produce bilirubinuria

Total

Sum of circulating fractions

Tracks burden, not etiology

Interpret fractionation with evidence of hemolysis and cholestatic injury.

Slide 25 · Hemolytic anemia increases pigment production

Accelerated erythrocyte destruction increases heme delivery to macrophages.

Macrophage catabolism produces more unconjugated bilirubin.

Hepatic conjugation can be overwhelmed by the increased load.

The resulting rise is predominantly unconjugated.

Mechanistic interpretation

The primary abnormality is pigment input rather than hepatocyte transport failure.

Slide 26 · Ineffective erythropoiesis can cause jaundice

Erythroid precursors may be destroyed before entering circulation.

Their heme still undergoes macrophage catabolism.

Pernicious anemia and thalassemia as examples.

The bilirubin pattern is predominantly unconjugated.

Mechanistic interpretation

Red-cell destruction may occur within marrow, not only in peripheral blood.

Slide 27 · Resorbing hematomas are a bilirubin source

Blood deposited in tissue is progressively broken down.

The heme load from a resolving hematoma increases bilirubin production.

Internal hemorrhage may similarly increase pigment production.

Unconjugated bilirubin predominance follows the upstream heme load.

Mechanistic interpretation

A high heme burden may arise without primary hepatobiliary disease.

Slide 28 · Drug interference can impair hepatic uptake

A transport defect may occur before conjugation.

Drug interference

Reduced membrane uptake

Unconjugated retention

Interference with hepatocyte carrier systems among causes of predominantly unconjugated hyperbilirubinemia.

Slide 29 · UGT1A1 deficiency produces a conjugation bottleneck

A functioning uptake step cannot compensate for defective glucuronidation.

Normal bilirubin arrival

Reduced UGT1A1 activity

Less glucuronide formed

Indirect bilirubin rises

This principle connects physiologic neonatal jaundice with inherited syndromes of varying severity.

Slide 30 · Major unconjugated pathways at a glance

Affected step

Representative settings

Principal consequence

Production

Hemolysis; Hematoma; Ineffective erythropoiesis

Heme-derived bilirubin load ↑

Uptake

Drug-related carrier interference

Hepatic bilirubin entry ↓

Conjugation

Neonatal immaturity; UGT1A1 variants

Glucuronide formation ↓

Each route creates predominantly unconjugated hyperbilirubinemia by a distinct mechanism.

Slide 31 · Gilbert syndrome: Limited conjugating capacity

Gilbert syndrome is an inherited cause of mild unconjugated hyperbilirubinemia.

Reduced UGT1A1 activity contributes in some cases.

The source also lists impaired hepatic uptake in some cases.

It is milder than severe Crigler–Najjar deficiency.

Mechanistic interpretation

The bilirubin fraction—not the eponym alone—links the syndrome to its mechanism.

Slide 32 · Crigler–Najjar type I: Severe conjugation failure

Severe UGT1A1 deficiency strongly limits bilirubin glucuronidation.

Unconjugated bilirubin can rise to dangerous levels.

A severe, potentially fatal neonatal phenotype.

Neurologic injury is driven by excess unbound bilirubin.

Mechanistic interpretation

A severe congenital enzyme defect makes an otherwise normal transport pathway inadequate.

Slide 33 · Crigler–Najjar type II retains enzyme activity

Residual UGT1A1 activity permits some bilirubin conjugation.

The clinical phenotype is milder than type I.

Indirect hyperbilirubinemia remains the characteristic pattern.

Residual activity explains the difference in severity.

Mechanistic interpretation

Enzyme activity exists on a spectrum; Phenotypes need not be equivalent.

Slide 34 · Inherited unconjugated syndromes: Mechanism

Syndrome

UGT1A1 function

Expected phenotype

Gilbert

Reduced in some cases; Uptake may contribute

Relatively mild

Crigler–Najjar type II

Residual activity

Less severe

Crigler–Najjar type I

Severe deficiency

Severe neonatal risk

Clinical severity parallels the extent of impaired conjugation, but is not defined by a single slide rule.

Slide 35 · Neonatal liver has limited UGT1A1 activity

UGT1A1 activity is low at birth.

Adult activity is reached over the first 3–4 months.

Transient predominantly unconjugated jaundice is common in week one.

The physiology reflects maturation of bilirubin conjugation.

Mechanistic interpretation

Newborn jaundice is partly developmental, not necessarily evidence of structural liver disease.

Slide 36 · The neonatal imbalance is time dependent

Conjugation gradually improves after birth.

Ongoing heme turnover

Immature UGT1A1

Indirect bilirubin increase

Hepatic maturation

The key distinction from severe inherited deficiency is progressive recovery of conjugating capacity in physiologic neonatal jaundice.

Slide 37 · Breastfeeding may increase unconjugated bilirubin

Breastfeeding can exacerbate unconjugated hyperbilirubinemia.

Deconjugating enzymes in breast milk are proposed contributors.

More intestinal deconjugation can favor bilirubin reabsorption.

The precise mechanism should not be treated as settled from this excerpt alone.

Mechanistic interpretation

This is a suggested mechanism in the source, not proof of a single universal cause.

Slide 38 · Excess free bilirubin threatens the neonatal brain

Albumin binding is protective but not absolute.

Indirect bilirubin rises

Unbound fraction increases

Tissue penetration

Neural injury

The vulnerable free fraction can diffuse into infant brain tissue and cause bilirubin encephalopathy (kernicterus).

Slide 39 · Kernicterus is not simply an elevated laboratory number

The brain injury mechanism requires circulating unbound bilirubin.

Most plasma unconjugated bilirubin is normally albumin-bound.

Marked pigment burden can increase the unbound fraction.

Infants are particularly vulnerable to neurologic injury.

Mechanistic interpretation

Risk is related to bilirubin handling and tissue exposure, not merely skin coloration.

Slide 40 · Phototherapy bypasses immature conjugation

Blue light changes pigment handling without fixing UGT1A1.

Unconjugated bilirubin

Blue-light photoisomerization

More soluble isomers

Excretion

Blue-light therapy as converting bilirubin into excretable soluble isomers until hepatic conjugation matures.

Slide 41 · Why conjugated bilirubin accumulates

The affected step shifts downstream of glucuronidation.

Conjugate formed

Excretion or bile flow impaired

Bilirubin retained in blood

Hepatocellular disease, bile duct injury, and obstruction commonly produce conjugated hyperbilirubinemia.

Slide 42 · Hepatocellular disease can produce direct jaundice

Hepatitis and cirrhosis are included among major causes.

Impaired hepatocyte bile formation or excretion retains conjugates.

Damage may simultaneously affect more than one handling step.

Therefore hepatocellular disease can have a mixed bilirubin profile.

Mechanistic interpretation

Fraction predominance guides interpretation but does not replace tissue and biochemical context.

Slide 43 · Canalicular transporter defects impair export

Conjugated bilirubin requires active canalicular transport.

Transport defects can produce hereditary conjugated hyperbilirubinemia.

Dubin–Johnson syndrome illustrates abnormal MRP2-dependent export.

Rotor syndrome is another inherited conjugated hyperbilirubinemia.

Mechanistic interpretation

In the source, both syndromes are described as clinically innocuous.

Slide 44 · Dubin–Johnson syndrome blocks bilirubin export

MRP2 is important for moving organic anions into canalicular bile.

MRP2 mutation

Reduced canalicular secretion

Conjugated bilirubin retention

The source associates the syndrome with a distinctive brown-black hepatocellular pigment and dark liver coloration.

Slide 45 · Dubin–Johnson pigment is distinct from bile plugs

Pathology mechanism

Brown-black melanin-like hepatocellular pigment

Conjugated hyperbilirubinemia

The pigment may darken the whole liver

Conceptual schematic only — not a histologic specimen or substitute for the diagnostic appearance.

Slide 46 · Rotor syndrome: A conjugated inherited phenotype

Rotor syndrome is grouped with hereditary conjugated hyperbilirubinemia.

An autosomal recessive, clinically innocuous condition.

The supplied excerpt does not specify its molecular transport mechanism.

Distinguish the named syndrome from the established MRP2 defect of Dubin–Johnson.

Mechanistic interpretation

Do not infer identical transport defects for Dubin–Johnson and Rotor from shared bilirubin fractionation.

Slide 47 · Acquired and inherited conjugated patterns

Inherited conditions

Acquired conditions

Dubin–Johnson syndrome

Rotor syndrome

Transport-handling abnormalities

Hepatitis or cirrhosis

Bile duct injury / autoimmune cholangiopathy

Mechanical duct obstruction

Direct bilirubin elevation identifies a downstream problem but not the particular disease.

Slide 48 · Cholestasis means retention of bile constituents

Bile formation may fail within hepatocytes.

Alternatively, bile drainage may be obstructed in ducts.

Both mechanisms retain bilirubin and other biliary solutes.

Not every instance of hyperbilirubinemia implies equivalent cholestatic injury.

Mechanistic interpretation

Cholestasis is a functional and morphologic concept, not merely a synonym for jaundice.

Slide 49 · Cholestasis has two broad anatomic entry points

Impaired formation / secretion

Obstructed bile flow

Defective hepatocyte bile export

Hepatocellular or canalicular dysfunction

May occur without a large-duct blockage

Impaired drainage within bile ducts

Upstream canalicular and ductal pressure

Can progress to fibrosis if sustained

Both routes may converge on bile pigment retention and hepatocyte injury.

Slide 50 · Bile plugs expand canalicular spaces

Normal canaliculus

Canalicular cholestasis

Retained bile pigment within expanded lumen

Pathology mechanism

Green-brown pigment accumulates within canaliculi.

Canaliculi become dilated by retained bile.

Pigment may also accumulate in hepatocytes.

Schematic of cholestatic canalicular pigment; Not an H&E image.

Slide 51 · Feathery degeneration reflects bile-salt injury

Pathology mechanism

Retention of bile salts produces hepatocyte swelling.

The cytoplasm takes on a foamy, feathery appearance.

This finding provides evidence of hepatocellular cholestatic stress.

Conceptual native-vector hepatocyte; Not diagnostic microscopy.

Slide 52 · Canalicular rupture transfers pigment to macrophages

Kupffer cell

Pathology mechanism

Retained bile may extravasate from ruptured canaliculi.

Kupffer cells engulf regurgitated bile pigment.

The resulting pigment may be seen in hepatic macrophages.

Schematic highlights leakage and pigment uptake rather than histologic detail.

Slide 53 · Adult large-duct obstruction has three major sources

Choledocholithiasis obstructs bile flow with stones.

Malignancies of biliary tree or pancreatic head may compress or invade ducts.

Postoperative or ischemic strictures may narrow bile ducts.

Primary sclerosing cholangitis can also create a large-duct obstructive picture.

Mechanistic interpretation

Localization of mechanical obstruction helps explain the cholestatic phenotype.

Slide 54 · Pediatric bile duct obstruction differs etiologically

Biliary atresia is an important infantile cause.

Cystic fibrosis may involve obstructive biliary disease.

Choledochal cysts can compromise bile drainage.

These should not be conflated with physiologic unconjugated neonatal jaundice.

Mechanistic interpretation

Anatomic and biochemical interpretation differs from normal maturation of UGT1A1.

Slide 55 · Duct obstruction produces upstream change

Obstruction impedes downstream bile passage.

Duct narrowed or blocked

Proximal bile accumulation

Duct dilation

Cholestatic liver injury

Early correction may reverse cholestatic change; Sustained obstruction can cause progressive tissue remodeling.

Slide 56 · Portal tract edema accompanies large-duct blockage

Reactive ductular structures

Pathology mechanism

Portal stroma expands with edema.

Ductular reaction develops at the portal–parenchymal interface.

Neutrophils may cluster around the newly prominent ductules.

Portal reaction is shown as a schematic, not a biopsy photomicrograph.

Slide 57 · A ductular reaction signals biliary stress

Ductules become prominent at the portal–parenchymal boundary.

This occurs in the setting of large-duct obstruction.

Associated edema expands the portal tract.

Neutrophils around ductules are described as pericholangitis.

Mechanistic interpretation

The ductular reaction is a tissue response to disturbed drainage rather than the obstructing lesion itself.

Slide 58 · Ascending cholangitis recruits neutrophils into ducts

Intraluminal inflammatory cells

Pathology mechanism

Neutrophils affect bile duct epithelium.

They can accumulate within duct lumens.

This differs from inflammation merely near ductules.

Schematic represents inflammatory location only; Not an authentic section.

Slide 59 · Obstruction facilitates ascending bacterial cholangitis

Stagnant bile favors infection of the biliary tree.

Enteric organisms including coliforms and enterococci.

Typical presentation involves fever, chills, abdominal pain, and jaundice.

Severe infection can lead to abscess, sepsis, and death.

Mechanistic interpretation

Clinical deterioration may reflect superimposed infection rather than obstruction alone.

Slide 60 · Persistent obstruction changes the liver architecture

Prolonged cholestasis may become irreversible.

Unrelieved duct blockade

Persistent ductular / portal injury

Fibrosis

Biliary cirrhosis

When the obstruction is corrected early, the initial cholestatic changes may be reversible.

Slide 61 · Advanced obstructive injury affects periportal hepatocytes

Periportal cells may develop feathery degeneration.

Bile pigment deposits accompany persistent cholestatic stress.

Robbins also describes Mallory hyaline in advanced obstruction.

These findings occur in a background of progressive portal fibrosis.

Mechanistic interpretation

The distribution connects duct-level obstruction to hepatocyte injury near portal tracts.

Slide 62 · Bile retention explains clinical pruritus

Pruritus is a recognized manifestation of cholestatic disease.

It accompanies disturbed handling of biliary constituents.

It is not explained by bilirubin accumulation alone.

Thus pruritus can help indicate a broader cholestatic process.

Mechanistic interpretation

Bilirubin is a useful marker of cholestasis, but is not the sole mediator of its symptoms.

Slide 63 · Xanthomas reflect altered cholesterol handling

Cholestatic disease may produce skin xanthomas.

These are focal accumulations of cholesterol.

Cholesterol is normally one of the components secreted in bile.

Their occurrence links impaired bile handling with extrahepatic deposition.

Mechanistic interpretation

Bile transport failure affects lipids as well as bilirubin.

Slide 64 · Reduced intestinal bile causes fat malabsorption

Bile salts normally emulsify dietary fats.

Cholestasis reduces effective bile delivery to the intestine.

Malabsorption may follow impaired micellar processing.

Fat-soluble vitamin deficiencies may develop.

Mechanistic interpretation

Digestive consequences are a functional extension of impaired bile secretion.

Slide 65 · Fat-soluble vitamin deficiency in cholestasis

Vitamin

Why risk increases

Teaching consequence

A

Impaired intestinal fat absorption

Deficiency may develop

D

Impaired intestinal fat absorption

Deficiency may develop

K

Impaired intestinal fat absorption

Deficiency may develop

The supplied Robbins excerpt specifically highlights vitamins A, D, and K; No numerical deficiency thresholds are asserted.

Slide 66 · Cholestasis alters laboratory enzyme patterns

Canalicular and biliary membranes contain characteristic enzymes.

Apical membrane injury / stress

ALP and GGT elevation

Cholestatic biochemical profile

Elevated alkaline phosphatase and γ-glutamyl transpeptidase (GGT) characterize cholestatic disease in the source.

Slide 67 · Urinary pigment differentiates bilirubin fractions

Predominantly unconjugated

Predominantly conjugated

Albumin-bound and insoluble

No direct filtration into urine

Hemolysis or conjugation defect likely

Water soluble

Can enter urine

Excretion or bile flow defect likely

Bilirubinuria supports a conjugated component; Absence must be interpreted with clinical context.

Slide 68 · First-pass reasoning begins with fractionation

This is a teaching decision tree, not a complete clinical diagnostic guideline.

Confirm serum bilirubin elevation

Determine dominant fraction

Identify mechanism

Seek cause

With indirect predominance, consider production, uptake, and UGT1A1; With direct predominance, consider hepatic disease, transport, and ducts.

Slide 69 · Mechanism-specific clues in jaundice

Pattern

Mechanism to test

Example

Indirect + increased heme turnover

Overproduction

Hemolytic anemia

Indirect + developmental setting

Reduced conjugation

Physiologic newborn jaundice

Direct + cholestatic features

Failed secretion or flow

Large-duct obstruction

Direct + inherited context

Conjugate transport / handling

Dubin–Johnson; Rotor

The table is mechanistic and illustrative; Clinical evaluation also considers additional findings.

Slide 70 · Case: Jaundice with accelerated red-cell turnover

A patient with an established hemolytic anemia develops yellowing of the conjunctiva.

Clinical information

Background: Excessive red-cell destruction

Question: Which bilirubin fraction should predominate?

Mechanistic answer

Predominantly unconjugated bilirubin

Heme turnover generates bilirubin faster than the liver can dispose of it.

Slide 71 · Case: A transient neonatal unconjugated rise

A newborn develops mild indirect bilirubin elevation during the first week.

Clinical information

Developmental period immediately after birth

No duct obstruction is described

Mechanistic answer

Physiologic immaturity of conjugation

UGT1A1 activity is initially low and progressively increases after birth.

Slide 72 · Case: Conjugated jaundice after biliary obstruction

An adult with choledocholithiasis develops jaundice and a cholestatic biochemical pattern.

Clinical information

Mechanical blockade of a large bile duct

Bile drainage is impaired

Mechanistic answer

Predominantly conjugated hyperbilirubinemia

Bile formation may continue upstream, but excretion into the intestine is obstructed.

Slide 73 · Case: Benign familial direct hyperbilirubinemia

A patient has longstanding hereditary conjugated hyperbilirubinemia without major hepatocellular symptoms.

Clinical information

Question: Which syndromes are in the differential?

No specific tissue pigment finding is supplied

Mechanistic answer

Dubin–Johnson or Rotor syndrome

Both are listed by Robbins as autosomal recessive inherited conjugated syndromes.

Slide 74 · Sepsis may impair bile handling without a stone

Sepsis can produce intrahepatic infection or ischemic injury.

Circulating microbial products can also alter bile secretion.

Robbins particularly emphasizes the latter during gram-negative infection.

The result can be cholestasis despite no primary large-duct blockage.

Mechanistic interpretation

Systemic inflammation provides an intrahepatic mechanism of cholestatic dysfunction.

Slide 75 · Sepsis-associated cholestasis may be ductular

Ductular bile concretions

Pathology mechanism

Canalicular bile plugs may be present.

Dilated canals of Hering and ductules can contain dark bile concretions.

Inflammation and hepatocellular injury are often relatively mild.

Schematic of ductular cholestasis; Not a source photomicrograph.

Slide 76 · Compare three cholestatic injury settings

Setting

Dominant mechanism

Source-associated finding

Large-duct obstruction

Blocked downstream bile flow

Portal edema / ductular reaction

Ascending cholangitis

Infection superimposed on biliary drainage problem

Intraluminal duct neutrophils

Sepsis cholestasis

Systemic microbial products impair intrahepatic bile handling

Ductular bile plugs; Mild inflammation

A shared conjugated bilirubin pattern can arise from very different tissue processes.

Slide 77 · Jaundice and cholestasis are related, not identical

Jaundice

Cholestasis

Visible accumulation of bilirubin

Reflects elevated circulating pigment

Can occur in hemolysis without cholestasis

Retention of biliary solutes

May include bile salts and cholesterol

Can cause pruritus and fat malabsorption

This distinction avoids labeling every indirect jaundice as a cholestatic disorder.

Slide 78 · A unified mechanistic model of hyperbilirubinemia

Locate the failed balance between input and clearance.

Pigment formed

Pigment transported

Pigment conjugated

Pigment secreted

Bile drained

Overproduction or upstream failure → indirect predominance; Downstream secretion or drainage failure → direct predominance, often with cholestasis.

Slide 79 · Three principles for clinicopathologic interpretation

Always separate bilirubin concentration from bilirubin fraction.

Interpret indirect elevation by production, uptake, and conjugation.

Interpret direct elevation by hepatocellular handling and bile flow.

Use morphology and clinical context to refine the mechanism.

Mechanistic interpretation

The biochemical pattern is an entry point, not a definitive disease diagnosis.

Slide 80 · Principal textbook source

Robbins, Cotran & Kumar: Pathologic Basis of Disease. 11th edition (2026).

Chapter 18: Liver and Gallbladder — Cholestatic Disease.

Bile Formation and Secretion; Pathophysiology of Hyperbilirubinemia.

Adjacent sections: neonatal and hereditary jaundice, large-duct obstruction, and cholestasis of sepsis.